O

    Opus Genetics, Inc. (IRD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.62
    -0.07 (-1.90%)

    Market Cap: $301.17M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(19/38)
    Avg Surprise
    -616.80%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.21 - $-0.10
    14 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate Drift
    90d ago$-0.16-3.7%
    60d ago$-0.16-3.0%
    30d ago$-0.16-3.0%
    7d ago$-0.15+0.5%
    Current$-0.15
    Revenue Consensus
    $2M
    Range$0 - $4M
    17 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.48
    Range$-0.79 - $0.17
    14 analysts
    Revenue Consensus
    $5M
    Range$-4457450 - $20M
    18 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.48---
    Sep 26EST
    		-$-0.15---
    Jun 26
    Reported Aug 6
    		$-0.14$-0.15+6.67%Beat-16.7%
    Mar 26
    Reported May 12
    		$-0.75$-0.14-435.71%Miss-134.4%
    Dec 25
    Reported Feb 25
    		$-0.21$-0.12-78.27%Miss+83.5%
    Sep 25
    Reported Nov 12
    		$-0.25$-0.13-92.31%Miss+13.8%
    Jun 25
    Reported Aug 13
    		$-0.12N/A+53.85%Beat+60.0%
    Mar 25
    Reported May 15
    		$-0.32$-0.34+5.88%Beat-10.3%
    Dec 24
    Reported Mar 31
    		$-1.27$-0.05-2573.68%Miss-504.8%
    Sep 24
    Reported Nov 12
    		$-0.29$-0.23-26.09%Miss-216.0%
    Jun 24
    Reported Aug 13
    		$-0.30$-0.28-7.14%Miss-25.0%
    Mar 24
    Reported May 10
    		$-0.29$-0.14-107.14%Miss-3.6%
    Dec 23
    Reported Mar 8
    		$-0.21$-0.05-320.00%Miss-112.4%
    Sep 23
    Reported Nov 13
    		$0.25$-0.23+208.70%Beat+213.6%
    Jun 23
    Reported Aug 11
    		$-0.24$-0.24+0.00%Beat+4.0%
    Mar 23
    Reported May 15
    		$-0.28$-0.16-75.00%Miss+20.0%
    Dec 22
    Reported Mar 31
    		$1.69$1.00+69.00%Beat+582.9%
    Sep 22
    Reported Nov 4
    		$-0.22$-0.29+24.14%Beat+12.0%
    Jun 22
    Reported Aug 12
    		$-0.25$-0.33+24.24%Beat+51.9%
    Mar 22
    Reported May 13
    		$-0.35$-0.35+0.00%Beat+25.5%
    Dec 21
    Reported Mar 31
    		$-0.35$-0.35+0.00%Beat+92.6%
    Sep 21
    Reported Nov 12
    		$-0.25$-0.36+30.56%Beat+24.2%
    Jun 21
    Reported Aug 12
    		$-0.52$-0.41-26.83%Miss+79.2%
    Mar 21
    Reported May 7
    		$-0.47$-0.83+43.37%Beat+19.0%
    Dec 20
    Reported Mar 31
    		$-4.70$-4.70+0.00%Beat-152.7%
    Sep 20
    Reported Nov 4
    		$-0.33$-0.33+0.00%Beat+83.2%
    Jun 20
    Reported Aug 10
    		$-2.50$-0.62-303.23%Miss-2.5%
    Mar 20
    Reported May 18
    		$-0.58$-0.15-286.67%Miss+85.7%
    Dec 19
    Reported Mar 16
    		$-1.86$-2.00+7.00%Beat+56.9%
    Sep 19
    Reported Dec 27
    		$-1.96$-1.96+0.00%Beat+76.0%
    Jun 19
    Reported Aug 7
    		$-2.44$-2.44+0.00%Beat+57.6%
    Mar 19
    Reported May 13
    		$-4.07$-0.93-337.63%Miss-21.1%
    Dec 18
    Reported Mar 8
    		$-4.32$-0.09-4700.00%Miss+25.0%
    Sep 18
    Reported Nov 5
    		$-8.16$-0.17-4700.00%Miss-325.0%
    Jun 18
    Reported Aug 6
    		$-5.76$-0.17-3288.24%Miss-400.0%
    Mar 18
    Reported May 7
    		$-3.36$-0.14-2300.00%Miss+92.2%
    Dec 17
    Reported Mar 13
    		$-5.76$-0.14-4014.29%Miss-442.1%
    Sep 17
    Reported Nov 6
    		$-1.92N/A+81.25%Beat+69.8%
    Jun 17
    Reported Aug 7
    		$1.92N/A+119.05%Beat-
    Mar 17
    Reported May 5
    		$-43.20$-8.00-440.00%Miss-
    Dec 16
    Reported Feb 27
    		$-1.06N/AN/ABeat-
    Sep 16
    Reported Nov 7
    		$-6.36N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-2.68EV/EBITDA-2.55x
    Price/FCF-8.50xFCF Yield-11.77%
    Profitability
    Profit Margin0.00%Operating Margin-2183.00%
    ROE-4797.00%ROIC-365.47%
    Financial Health
    Debt/Equity-2.79xInterest CoverageN/A
    Current Ratio12.19xQuick Ratio12.19x
    Trading Statistics
    Beta0.58Avg Volume821.31K
    52-Week High$5.8152-Week Low$1.22

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.90
    SMA 20$3.81
    SMA 50$3.73
    SMA 200$3.64
    EMA 10$3.82
    EMA 20$3.79
    EMA 50$3.83
    EMA 200$3.54

    MACD

    Line: 0.03Signal: 0.05Hist: -0.02

    ADX

    ADX: 19.1+DI: 22.4-DI: 24.2

    Aroon & PSAR

    Aroon Up84.0
    Aroon DownN/A
    PSAR$4.40

    Bollinger Bands

    Upper Band$4.16
    Lower Band$3.46
    %B Position1821%(Upper)
    Band Width0.23

    RSI (14-Day)

    Neutral
    44.6

    Momentum Oscillators

    Stoch %K20.9
    Stoch %D30.5
    Williams %R-88.0
    ROC (10d)-0.8%
    Momentum-0.03
    CCI (20d)-89.8
    MFI (14d)60.1

    Volatility Measures

    ATR (14d)$0.27(7.3%)
    StdDev (20d)0.17
    Hist Vol59.2%(High)

    Volume Flow

    VWAP$3.62
    OBV84.4M
    AD Line-24.1M
    CMF (20d)-0.097

    Volume Metrics

    Avg Vol (20d)775.8K
    Vol Ratio0.7x
    VWMA (20d)$3.85

    Pivot Points

    R3$4.05
    R2$3.96
    R1$3.82
    Pivot Point$3.73
    S1$3.59
    S2$3.50
    S3$3.36

    Advanced Oscillators

    TSI4.74
    Ultimate Osc33.5
    KST78.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$755,000$2.16M$3.87M$3.08M$2.88M$4.37M$4.30M$3.87M$1.11M$1.71M$1.69M$11.94M
    Cost of Revenue$0$0$13,000$0$0$0$7.78M$0$0$0$4.70M$0
    Gross Profit$755,000$2.16M$3.87M$3.08M$2.88M$4.37M$4.30M$3.87M$1.11M$1.71M$1.69M$11.94M
    Operating Expenses$17.23M$16.52M$15.32M$11.39M$11.79M$14.30M$42.33M$11.88M$9.44M$9.42M$7.12M$5.55M
    R&D$11.21M$10.58M$10.43M$6.41M$6.02M$7.95M$35.03M$8.98M$6.09M$4.75M$3.84M$3.49M
    SG&A$6.03M$5.94M$4.89M$4.98M$5.77M$6.35M$7.30M$2.89M$3.35M$4.67M$3.28M$2.06M
    Operating Income$-16,480,000$-14,364,000$-11,453,000$-8,311,000$-8,906,000$-9,929,000$-38,029,000$-8,009,000$-8,328,000$-7,708,000$-5,429,000$6.39M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$69,000$5.07M$68,000$0$0$0$0$0$0$0$811,000
    Income Before Tax$-8,098,000$-65,535,000$-16,523,000$-17,454,000$-7,420,000$-8,194,000$-35,135,000$-7,526,000$-7,765,000$-7,106,000$-4,797,000$5.58M
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$-2,000$14,000
    Net Income$-8,098,000$-65,535,000$-16,523,000$-17,454,000$-7,420,000$-8,194,000$-35,135,000$-7,526,000$-7,765,000$-7,106,000$-4,795,000$5.56M
    EBITDA$-8,084,000$-65,453,000$-16,449,000$-17,373,000$-7,406,000$-8,181,000$-35,125,000$-7,526,000$-7,765,000$-7,106,000$-4,794,000$5.58M
    EBIT$-8,098,000$-65,466,000$-16,462,000$-17,386,000$-7,420,000$-8,194,000$-35,135,000$-7,526,000$-7,765,000$-7,106,000$-4,797,000$5.58M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IRD

    Frequently Asked Questions About IRD

    Does IRD pay dividends?
    Opus Genetics, Inc. (IRD) does not currently pay a regular dividend.
    What is IRD's market cap?
    Opus Genetics, Inc. (IRD) has a market capitalization of $301.17M with a current stock price of $3.62.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In